With EULAR in full swing in Madrid, much of the focus, as in other therapeutic areas, has been on the use of biomarkers to guide personalized treatment options. 16 June 2017
At the Annual European Congress of Rheumatology, in Madrid, Basel-based Novartis has announced new data on Cosentyx in ankylosing spondylitis (AS) and psoriatic 15 June 2017
US biotech major Biogen is presenting real-world data studies demonstrating the safety and efficacy Benepali, the company’s biosimilar version of Enbrel (etaner 15 June 2017
South Korean biopharmaceutical firm Celltrion has showcased data supporting the efficacy and safety of Truxima (biosimilar rituximab) in advanced follicular lym 14 June 2017
Belgian pharmaceutical company UCB (Euronext Brussels: UCB) has unveiled highlights from its forthcoming data presentations at the leading rheumatology conferen 14 June 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.